Advertisement
Advertisement
LIMN
Liminatus Pharma, Inc. Class A Common Stock
4.18
USDSponsored
+0.15
+3.72%
Sep 24, 15:59 UTC -4
Closed
Pre-Market
4.22
+0.04
+0.91%
Liminatus Pharma, Inc. Class A Common Stock Financial Snapshot
| Market Cap | 5.67M |
| Beta | 5.30 |
| Earnings Per Share (EPS) | -23.50 |
| Price-to-Book (P/B) Ratio | 15.14 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 479.85% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -- |
| Current Ratio | 1.12% |
| Free Cash Flow | -2.99M |
